What was the primary driver of the significant increase in net income?

The primary driver of the significant increase in net income was the acquisition of Trigon Healthcare, Inc. in July 2002, which contributed substantially to revenue and operating results across its newly formed Southeast segment. Strong organic growth and improved operational efficiencies also played a role.

How did the company manage the increase in cost of care?

The company managed the approximate 11% increase in cost of care through a combination of strategies including premium rate increases in its core businesses, enhanced disease management and advanced care management programs, disciplined pricing, and a shift in business mix towards self-funded arrangements where appropriate.

What is the company's outlook on future growth and integration?

The company continues to focus on integrating the Trigon acquisition, expecting to achieve significant synergies. Organic membership growth remains strong, particularly in National Accounts, Local Large Group, and Individual segments, suggesting a positive outlook for continued expansion.

Are there any significant legal proceedings that could impact the company's financial health?

While the company is involved in various legal proceedings, including a significant past litigation matter that was recently resolved and paid in March 2003, the company states its belief that any liabilities arising from ongoing litigation are unlikely to have a material adverse effect on its consolidated financial position or results of operations.

ELV 10-Q Quarterly Report Q1 FY2003 — Revenue, Net Income, EPS

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) reported strong performance for the first quarter ended March 31, 2003, with net income rising 92% year-over-year to $191.7 million, or $1.36 per diluted share. This significant growth was largely driven by the acquisition of Trigon Healthcare, Inc. in July 2002, which contributed substantially to revenue and operating gain across its newly formed Southeast segment. Revenue surged 46% to $4.02 billion, boosted by organic growth and the Trigon acquisition. The company demonstrated improved operational efficiency with an operating margin of 6.5%, up from 3.9% in the prior year's quarter. While cost of care increased by approximately 11% for core businesses, the company managed this effectively through premium rate increases and cost containment strategies, leading to a favorable benefit expense ratio. Investors should note the company's continued focus on strategic expansion and integration, alongside a robust capital position and ongoing share repurchase program.

Key Highlights

1Net income increased significantly by 92% to $191.7 million ($1.36 per diluted share) compared to the prior year's quarter.
2Total operating revenue grew by 46% to $4.02 billion, largely attributable to the acquisition of Trigon Healthcare, Inc.
3The company achieved a higher operating margin of 6.5%, an improvement from 3.9% in the same period last year, indicating enhanced operational efficiency.
4Same-store membership grew by 10%, demonstrating solid organic growth in key business lines such as National Accounts, Local Large Group, and Individual.
5Cost of care increased by approximately 11% for core businesses, but was managed effectively through premium adjustments and efficiency measures, resulting in a lower benefit expense ratio.
6The company repurchased approximately 1.6 million shares of common stock for $91.0 million, signaling a commitment to shareholder returns.

Elevance Health, Inc. Quarterly Report for Q1 Ended Mar 31, 2003

Summary

Key Highlights

Frequently Asked Questions